GlucoTrack, Inc. (GCTK) NASDAQ
0.65
-0.0199(-2.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.65
-0.0199(-2.97%)
Currency In USD
| Previous Close | 0.67 |
| Open | 0.66 |
| Day High | 0.67 |
| Day Low | 0.65 |
| 52-Week High | 15.9 |
| 52-Week Low | 0.58 |
| Volume | 370,825 |
| Average Volume | 4.65M |
| Market Cap | 368,846 |
| PE | -0.02 |
| EPS | -31.22 |
| Moving Average 50 Days | 0.9 |
| Moving Average 200 Days | 3.92 |
| Change | -0.02 |
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
GlobeNewswire Inc.
Mar 10, 2026 12:01 PM GMT
RUTHERFORD, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes,
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
GlobeNewswire Inc.
Jan 29, 2026 1:01 PM GMT
RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes,
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
GlobeNewswire Inc.
Dec 30, 2025 1:00 PM GMT
Rutherford, NJ., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announc